NCT06674044View on ClinicalTrials.gov

Effect of SLC01B1 (rs2306283) Polymorphism on the Efficacy and Safety Profile of Atorvastatin in Pakistani Population

CompletedOBSERVATIONAL

Enrollment

100

Participants

Timeline

Start Date

December 1, 2023

Primary Completion Date

July 31, 2024

Study Completion Date

August 31, 2024

Conditions

Hyperlipidemias

Interventions

GENETIC

Atorvastatin

Atorvastatin 10mg once a day for 1 month

Trial Locations (1)

Unknown

IIMC, Riphah International University, Islamabad

All Listed Sponsors

lead

Riphah International University

OTHER

NCT06674044 - Effect of SLC01B1 (rs2306283) Polymorphism on the Efficacy and Safety Profile of Atorvastatin in Pakistani Population | Biotech Hunter | Biotech Hunter